HPV vaccination reduces cervical cancer across all socioeconomic groups in England

May 16 2024BMJ The human papillomavirus vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.

In England, the HPV vaccination programme began in 2008, with catch-up vaccination for 14-18 year olds from 2008-10. But because cervical cancer rates have always been higher in the most deprived groups, there is concern that HPV vaccination could benefit those at greatest risk of cervical cancer the least.

Between 1 January 2006 and 30 June 2020 there were 29,968 diagnoses of cervical cancer and 335,228 of grade 3 precancerous cervical lesions in women aged 20-64 years. The highest rates remained among women living in the most deprived areas, but the HPV vaccination programme had a large effect in all five levels of deprivation.

For women offered catch-up vaccination at age 14-18, CIN3 rates decreased more in those from the least deprived areas than from the most deprived areas. However, for cervical cancer, the strong downward gradient from high to low deprivation seen in the older unvaccinated cohort was no longer present among those offered the vaccine.

As such, they conclude: "The HPV vaccination programme in England has not only been associated with a substantial reduction in incidence of cervical neoplasia in targeted cohorts, but also in all socioeconomic groups."

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New study shows continued high effectiveness of HPV vaccination in EnglandThe human papillomavirus (HPV) vaccination program in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ.
Source: medical_xpress - 🏆 101. / 51 Read more »

Cervical cancer vaccine roll-out shows efficacy in reducing cervical cancer and other HPV-related diseaseWith the creation of safe and efficacious vaccines to target human papillomavirus in the first decade of this century, WHO has an ambitious target to lower cervical cancer incidence (mostly caused by HPV) and mortality by 30% by 2030, meaning each country has a target of vaccinating 90% of girls by age 15, 70% of women receiving a high precision...
Source: medical_xpress - 🏆 101. / 51 Read more »

Study finds school entry requirements linked to increased HPV vaccination ratesA new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.
Source: medical_xpress - 🏆 101. / 51 Read more »

HPV vaccination rates increase with school entry requirements, study findsA new study from researchers at Wake Forest University School of Medicine shows that school entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations.
Source: NewsMedical - 🏆 19. / 71 Read more »

HPV vaccine prevents 90% of cervical cancer cases – and could eradicate killer disease ‘in our lif...Cervical cancer warning signs you should NEVER ignore, with Doctor Philippa Kaye
Source: TheSun - 🏆 64. / 61 Read more »